Amira A Boseila

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Health Risk Assessment

Hepatitis C Virus

Top Venues

Molecular pharmaceutics

Materials (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Fouad Damiri, Swetha Andra, Nagavendra Kommineni, Satheesh Kumar Balu, Raviteja Bulusu, Amira A Boseila, Damilola O Akamo, Zubair Ahmad, Farhat S Khan, Md Habibur Rahman, Mohammed Berrada, Daniela Simona Cavalu
Recent Advances in Adsorptive Nanocomposite Membranes for Heavy Metals Ion Removal from Contaminated Water: A Comprehensive Review. Materials (Basel, Switzerland) 15 (15) (2022)
Ayman Abo Elmaaty, Khaled M Darwish, Amani Chrouda, Amira A Boseila, Mohamed A Tantawy, Sameh S Elhady, Afzal Basha Shaik, Muhamad Mustafa, Ahmed Ali Al-Karmalawy
In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity. ACS omega 7 (1) (2021)
Amira A Boseila, Amal Y Abdel-Reheem, Emad B Basalious
Design of bile-based vesicles (BBVs) for hepatocytes specific delivery of Daclatasvir: Comparison of ex-vivo transenterocytic transport, in-vitro protein adsorption resistance and HepG2 cellular uptake of charged and β-sitosterol decorated vesicles. PloS one 14 (7) (2019)
Amira A Boseila, Hassan M Rashed, Tamer M Sakr, Amal Y Abdel-Reheem, Emad B Basalious
Superiority of DEAE-Dx-Stabilized Cationic Bile-Based Vesicles over Conventional Vesicles for Enhanced Hepatic Delivery of Daclatasvir. Molecular pharmaceutics 16 (10) (2019)